BURLINGTON, Mass., Sept. 24, 2015 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) today announced that its December 3rd Analyst Day will include presentations by two vascular surgeons in addition to presentations by company executives.
The two surgeons are R. Clement Darling, III, MD Chief, Vascular Surgery, Albany Medical Center and Alan Dardik, MD/PhD, Professor of Surgery, Yale University.
Dr. Darling will discuss the future of open surgery vs. endovascular procedures, and Dr. Dardik will cover the role of biologics in vascular surgery.
The event will be held at Ruth’s Chris in New York, 8:30 a.m. – 12:45 p.m. Analysts and investors are invited to attend. RSVP to Investor Relations at email@example.com.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Beth Kurth +1-781-425-1659 firstname.lastname@example.org
Source:LeMaitre Vascular, Inc.